Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/1996
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735889A1 A novel tumor suppressor gene
10/09/1996EP0735887A1 $i(IN UTERO) GENE THERAPY FOR FETUSES
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0648123B1 INHIBITORS OF PROTEIN TYROSINE-PHOSPHATASE $g(a) FOR TREATMENT OF TUMORS
10/09/1996CN1133064A GRB3-3 gene, variants and uses thereof
10/09/1996CN1133049A Melanona-inhibiting protein
10/09/1996CN1132791A Recombinant DNA viral vector for transfecting animal cells
10/08/1996US5563255 Antisense oligonucleotide modulation of raf gene expression
10/08/1996US5562904 Retroviral transduction of cells using soluble complement inhibitors
10/03/1996WO1996030544A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa
10/03/1996WO1996030536A1 Egf-targeted nucleic acid delivery
10/03/1996WO1996030535A1 Gene transfer into the kidney
10/03/1996WO1996030534A1 Adenovirus vectors for gene therapy
10/03/1996WO1996030533A1 Pseudotyped retroviral particles
10/03/1996WO1996030532A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
10/03/1996WO1996030524A1 Human dna ligase iii
10/03/1996WO1996030516A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996WO1996030512A1 Conditional expression system
10/03/1996WO1996030504A1 Modified viral envelope polypeptide
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030402A1 Nucleotide and protein sequences of lats genes and methods based thereon
10/03/1996WO1996030385A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996WO1996030051A1 Use of surfactants for introducing genetic material into lung cells
10/03/1996WO1996030050A1 Gene therapy by secretory gland expression
10/03/1996WO1996030031A1 Isolated stromal cells and methods of using the same
10/03/1996WO1996026285A3 Methods and compositions for administering gene therapy vectors
10/03/1996WO1996023884A3 Human peroxisome proliferator activated receptors
10/03/1996WO1996022373A3 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma
10/03/1996CA2217009A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996CA2216878A1 Viral vectors and their use for treating hyperproliferative disorders, in particular restenosis
10/03/1996CA2216807A1 Diagnostic and therapeutic system for crohn's disease and colitia ulcerosa
10/03/1996CA2216702A1 Nucleotide and protein sequences of lats genes and methods based thereon
10/03/1996CA2216445A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
10/03/1996CA2216149A1 Gene therapy by secretory gland expression
10/03/1996CA2215143A1 Isolated stromal cells and methods of using the same
10/03/1996CA2214499A1 Gene transfer into the kidney
10/03/1996CA2214451A1 Conditional expression system
10/02/1996EP0734448A1 Gene therapy for restenosis using an adenoviral vector
10/02/1996EP0734442A1 Diagnosis of metastatic cancer by the mts-1 gene
10/02/1996EP0734440A1 Tumor cell fusions and methods for use of such tumor cell fusions
10/02/1996EP0734436A1 Inhibition of dna methyltransferase
10/02/1996EP0734391A1 Pna-dna-pna chimeric macromolecules
10/02/1996EP0734264A1 Compositions that specifically bind to colorectal cancer cells and methods of using the same
10/02/1996EP0734251A1 Method of transmitting a biologically active material to a cell
10/02/1996EP0653943A4 Targeting somatic gene therapy to joints.
10/01/1996US5561063 Recombinant human cytomegalovirus containing foreign gene
09/1996
09/26/1996WO1996029423A1 Compositions and methods for inducing infection by retroviral vectors outside of their host range
09/26/1996WO1996029422A1 Nucleic acid carrier
09/26/1996WO1996029421A1 Vectors for gene delivery
09/26/1996WO1996029413A2 Dna encoding human papilloma virus type 18
09/26/1996WO1996029411A1 Protein production and delivery
09/26/1996WO1996029410A1 In vivo generation of antibodies against antigens secreted in a host by transfected mel cells
09/26/1996WO1996029409A2 Rage tumor rejection antigens
09/26/1996WO1996029408A1 Il-17 receptor
09/26/1996WO1996029407A2 Cellubrevin homologs
09/26/1996WO1996029398A1 Delivery and expression of heterologous genes using upstream enhancer regions of mammalian gene promoters
09/26/1996WO1996029395A1 Cell culture method
09/26/1996WO1996029393A1 Recombinant human immunodeficiency virus-producing cell
09/26/1996WO1996029337A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996WO1996029096A1 Gene transfer preparation
09/26/1996WO1996029091A1 Treatment of papillomavirus-associated lesions using interleukin-12
09/26/1996WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides
09/26/1996WO1996021014A3 Production and administration of high titer recombinant retroviruses
09/26/1996CA2216284A1 Thiono triester modified antisense oligodeoxynucleotide phosphorothioates
09/26/1996CA2216147A1 Cellubrevin homologs
09/26/1996CA2215618A1 Protein production and delivery
09/26/1996CA2215525A1 Treatment of papillomavirus-associated lesions using interleukin-12
09/26/1996CA2215162A1 Vectors for gene delivery
09/26/1996CA2214385A1 Cell culture method
09/26/1996CA2211448A1 Rage tumor rejection antigens
09/25/1996EP0733373A2 Compositions and methods for increasing the immunogenicity of tumor cells by administration of B7 and CD2-transfected cells
09/25/1996EP0733370A1 Antagonistic inhibitor against mesenchymal cell growth
09/25/1996EP0733110A1 Tuberous sclerosis 2 gene and uses thereof
09/25/1996EP0733103A1 Generation of high titers of recombinant aav vectors
09/25/1996EP0733068A1 METHODS AND COMPOSITIONS FOR THE SUPPRESSION OF $i(NEU) MEDIATED TRANSFORMATION
09/25/1996EP0733066A1 Pretargeting methods and compounds
09/25/1996EP0733057A1 Origin of replication complex genes, proteins and methods
09/25/1996EP0732943A1 Three-step pretargeting methods and compounds
09/25/1996EP0732941A1 Modulation of vascular cell adhesion molecule expression through novel oligonucleotide interactions
09/25/1996EP0732940A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes
09/25/1996EP0732929A1 Therapeutic use of cis-element decoys in vivo
09/25/1996EP0732875A1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5)
09/25/1996CN1131950A Recombinant C140 receptor and its agonists and antagonists
09/24/1996US5559099 Penton base protein and methods of using same
09/24/1996US5559022 Liver reserve cells
09/24/1996US5558995 Peptides which are derived from tumor rejection antigen precursor molecule MAGE-1, which complex to MHC molecule HLA-C clone 10, and uses thereof
09/24/1996CA2172436A1 Compositions and methods for increasing the immunogenicity of tumor cells
09/19/1996WO1996028564A1 Novel recombinant dna vectors for gene therapy
09/19/1996WO1996028563A1 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
09/19/1996WO1996028553A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy
09/19/1996WO1996028541A1 Method for in vitro preconditioning of myoblasts before transplantation
09/19/1996WO1996028461A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-Xp FAMILY AND USES THEREOF
09/19/1996WO1996028190A1 Non-invasive imaging of gene transfer
09/19/1996WO1996028189A1 A double transdominant fusion gene and protein
09/19/1996WO1996028188A2 Method of transmitting target-oriented substances
09/19/1996WO1996028029A1 Immunoisolation
09/19/1996WO1996017865A3 Genes and gene products for use in the diagnosis of degenerative nerve damage
09/19/1996CA2215383A1 Human tumor necrosis factor receptor
09/19/1996CA2215039A1 Immunoisolation
1 ... 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 ... 870